Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Press release |
28 March 2012
HIV/AIDS Intellectual property and trade

Losing ground in the struggle against HIV/AIDS and tuberculosis

3 min
MDR-TB patient Rohatay Abdullaeva at her home with a grandson Atabek and daughter Nadira, town of Hojeily, Karakalpakstan (Uzbekistan). Photograph by Natalia Sergeeva Photograph by Natalia Sergeeva
Press release
Press release |
20 March 2012
Tuberculosis
South AfricaUzbekistanIndia

Alarming Scale of Multidrug-Resistant Tuberculosis Requires Rapid Response to Avert Emerging Global Crisis

Press release |
20 March 2012
Intellectual property and trade Tropical & neglected diseases
Brazil

Argentina joins Brazil in producing life-saving drug for neglected disease

Kala Azar in Bihar, India. Sadar Hospital, Vaishali District. In partnership with the State Health Society-Bihar, MSF has managed a Kala Azar diagnosis and treatment project in Vaishali District since 2007, and has treated more than 10,000 patients free-of-charge within government facilities. Photograph by Angel Navarrete
Press release
Press release |
14 March 2012
Tropical & neglected diseases
South AfricaIndia

MSF Calls for a Spotlight on Kala Azar

4 min
Tribal villagers wait for care at the MSF mobile Clinic in Jaigur, Dantewara district. Photograph by Jean-Marc Giboux
Press release
Press release |
12 March 2012
HIV/AIDS Intellectual property and trade
India

India Issues First Compulsory Licence

Press release |
01 March 2012
Intellectual property and trade Malnutrition
Mali

Mauritania: Food insecurity threatens as thousands of Malian refugees gather in desert

Photograph by Michael Goldfarb Photograph by Michael Goldfarb
Press release
Press release |
23 February 2012
HIV/AIDS Intellectual property and trade
India

As Novartis Shareholders meet, MSF Urges Company to Drop Court Case in India

Press release |
22 February 2012
HIV/AIDS Intellectual property and trade Tuberculosis
Myanmar

MSF calls for urgent action to save lives in Myanmar

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury